Search Results 301-310 of 671 for ������������������������ ������������KaKaotalk:PC53���24������ ���������������

  1. Publications - Paul M. McKie, M.D. - Mayo Clinic

    2013 Jun 18; 61 (24):2456-2460 Epub 2013 Apr 16. View PubMed; Ichiki T, Boerrigter G, Huntley BK, Sangaralingham SJ, McKie PM, Harty GJ, Harders GE, Burnett ...

  2. Health Topics - Mayo Clinic News Network

    Mayo Clinic is No. 1 on Newsweek's list of "World's Best Smart Hospitals" and has seven No. 1 rankings in "World's Best Specialized Hospitals." Mayo[...] ...

  3. A Study Testing the Effectiveness and Safety of KPL-301 in Patients with Giant Cell Arteritis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Lesions in the AQP4-enriched postrema - Mayo Clinic

    On the left, MRI shows lesions in the AQP4 -enriched postrema, characteristic of some patients with NMOSD . On the right, MRI of a patient with sarcoidosis ...

  5. A Study Using Gallium-68 PSMA-11 and C-11 Choline PET Imaging to Detect Metastatic Prostate Cancer in Patients - Mayo Clinic

    About this study. The purpose of this study is to examine PSMA and C-11 Choline PET in patients with suspected metastatic prostate cancer who have been ...

  6. A Study to Evaluate TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of TAK-018 in reducing endoscopic recurrence of intestinal inflammation in postoperative participants ...

  7. Ketorolac (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Dosing · Adults and children 2 years of age and older—Use one drop in the affected eye(s) 4 times a day beginning 24 hours after surgery and for 2 weeks after ...

  8. Dr. Paul Limburg Archives - Mayo Clinic News Network

  9. Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

    About this study. This phase II trial studies how well combination chemotherapy and pralatrexate works in treating patients with non-Hodgkin lymphoma (NHL).

  10. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

    The study will be conducted in three parts. Part 1 is a dose escalation phase to determine the maximum tolerated dose (MTD) of INCB040093, a PI3Kδ inhibitor, or ...